A striking finding is that in both the human and murine models of AD, disruption of mitochondrial activities caused by tau, amyloid‐beta, or both pathogenic aggregates has been identified much earlier than the formation of NFTs and amyloid plaques, which are considered to be the disease's defining characteristics.4, 5. The gene discussed is MAPT; the disease is Alzheimer disease.